Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results

PR Newswire August 1, 2017

Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support

PR Newswire July 31, 2017

Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017

PR Newswire May 15, 2017

Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call

Accesswire May 15, 2017

Cumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results

PR Newswire May 8, 2017

New Kristalose® Growth Driver Established Through Co-Promotion Agreement

PR Newswire April 26, 2017

Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use

PR Newswire March 27, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.

Business Wire March 17, 2017

Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

PR Newswire March 7, 2017

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results

PR Newswire February 28, 2017

Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics

PR Newswire February 7, 2017

U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case

PR Newswire January 30, 2017

Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors

PR Newswire January 16, 2017

Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect®

PR Newswire January 9, 2017

Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products

PR Newswire November 16, 2016

Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing

Canada NewsWire November 7, 2016

Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results

PR Newswire November 1, 2016

Public Company Executives to Present Online to Investors on November 3

Canada NewsWire October 31, 2016

Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com November 3

Canada NewsWire October 28, 2016

Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results

PR Newswire October 25, 2016